PF4 and COVID-19: Recently, platelet-activating spike/anti-spike and histone/anti-histone IgG complexes have been associated with some VITT cases that occurred after mRNA COVID-19 vaccination whose sera tested negative for anti-PF4 antibodies but were still able to induce FcγRIIA-mediated platelet activation (Table 1) [14,15].